Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00003597 Background | Nov 1998 → Oct 2004 | cancer | Children's Oncology Group | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003597 ↗ |
| Modality | Protein / enzyme biologic | “Biological: G-CSF” NCT00003597 ↗ |
| Route | Subcutaneous | “G-CSF (5 μg/kg/d) as a daily subcutaneous injection beginning on Day 5” NCT00003597 ↗ |